DHA Kinase Polyclonal Antibody

Rabbit Anti-DHA Kinase Polyclonal Antibody

Product Specifications

Background

TKFC is a member of the family of dihydroxyacetone kinases, which have a protein structure distinct from other kinases. The product of TKFC phosphorylates dihydroxyacetone, and also catalyzes the formation of riboflavin 4',5'-phosphate (aka cyclin FMN) from FAD. Several alternatively spliced transcript variants have been identified, but the full-length nature of only one has been determined.

CAS Number

9007-83-4

Product Name Alternative

DAK; Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase; cyclizing

Gene ID

26007

Accession Number

Q3LXA3

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from the Internal region of human DHA Kinase at AA rangle: 60-140

Clonality

Polyclonal

Tag

Bifunctional ATP-dependent dihydroxyacetone kinase

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

59kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

DHA Kinase Polyclonal Antibody detects endogenous levels of DHA Kinase protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:200-1:1000; ELISA 1:20000; IF 1:20-50